← Leaderboards
Paul Da Silva Jardin
Vascumab, Llc
$600,749
Attributed
$600,749
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $405.8K · FY2017–18$500K$375K$250K$125K$0
'17
'18
Funding mix
By agency
NIH$600,749 · 1
By mechanism
N01$600,749 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Aortic Aneurysm”
- Magali Noval Rivas · Cedars-Sinai Medical Center$5,021,319
- Gregory Andrew Roth · University Of Washington$3,181,247
- Ajay Houde · Annoviant, Inc$3,028,801
- Francesca Seta · Boston University Medical Campus$2,979,770
- Kenneth W. Mahaffey · Stanford University$2,629,431
- Bradley Graham Leshnower · Emory University$2,211,662
Research focus
Aortic AneurysmAreaClinical CandidateCoronary ArteriosclerosisDissectionDrug KineticsHdac4 GeneHeartHeart FailureHistone Deacetylase InhibitorHypertensionHypoxiaInhibitor/AntagonistInterestIntracranial ArteryLeadLymphatic DiseasesLymphatic SystemMonocrotalineOralPeripheral Arterial DiseaseProduct DevelopmentProgramsPulmonary Arterial Hypertension